Sagimet-Logo-for-light-bg-FIN.png
Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 13, 2023 08:00 ET | Sagimet Biosciences Inc.
On track to report topline week 52 liver biopsy results from Phase 2b FASCINATE-2 trial with denifanstat in the first quarter of 2024 Two abstracts, including late-breaker, accepted at the American...
BioTech Breakthrough Awards Badge[1] copy.jpg
HistoSonics Edison System Recognized With BioTech Breakthrough Award For “MedTech Innovation Of The Year”
November 08, 2023 08:02 ET | BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
Nouveau Logo communiqué de presse.JPG
Theratechnologies présente à l’ID Week des données montrant que la tésamoréline réduit le tissu adipeux viscéral et l’accumulation de graisse dans le foie chez les personnes vivant avec le VIH et traitées par des inhibiteurs de l’intégrase (INSTI)
October 13, 2023 07:30 ET | Theratechnologies
La réduction significative de l’accumulation du tissu adipeux viscéral associée aux INSTI obtenue avec la tésamoréline contraste avec l’augmentation de ce tissu observée chez les patients prenant un...
Nouveau Logo communiqué de presse.JPG
Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs)
October 13, 2023 07:30 ET | Theratechnologies
Significant reduction in INSTI-associated VAT accumulation with tesamorelin contrasts with VAT increase in patients taking placebo VAT accumulation observed after 12 months on...
Growth in Patient an
Growth in Patient and Medical Community Engagement in NASH Community Persists Despite Recent Regulatory Disappointment
June 08, 2023 07:19 ET | Global Liver Institute
Washington, D.C., June 08, 2023 (GLOBE NEWSWIRE) -- Today is International NASH Day, a time where healthcare experts and community members around the globe step up and raise awareness of the most...
researchdrivelogo.jpg
Global Cancer Stem Cells Market Predicted to Register a Revenue of $1,722.7 Million and Grow at a CAGR of 10.3% Over the Estimated Timeframe 2019-2026 [180-Pages] | Released by Research Dive
April 12, 2023 09:02 ET | Research Dive
New York, USA, April 12, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research dive, the global cancer stem cells market is anticipated to garner $1,722.7 million in revenue and rise...
February is Rare Liver Diseases Month
Obstetric and Neonatal Professionals Must Work More Closely with Pregnant People to Identify Liver Diseases Early
February 01, 2023 11:11 ET | Global Liver Institute
Washington, D.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) launches its third annual #RareAware campaign today to raise awareness of and build resources for liver health...
Sm-logo-resized.jpg.png
Organ Preservation Market is anticipated to reach a market value of USD 377.97 million by 2030, with a CAGR of 6.93%
June 24, 2022 11:26 ET | STRATEGIC MARKET RESEARCH LLP
New York, United States, June 24, 2022 (GLOBE NEWSWIRE) -- The factors driving the organ preservation market are a rising geriatric population, a rise in traumatic accidents and increasing cases of...
International NASH D
International NASH Day Highlights a Common – But Unfamiliar – Liver Disease
June 08, 2022 18:04 ET | Global Liver Institute
Washington, D.C., June 08, 2022 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) calls attention to NASH by leading the 5th annual International NASH Day on June 9. The number of people with this...
researchdrivelogo.jpg
Global Cancer Stem Cells Market Estimated to Surpass $1,722.7 Million by 2026, and Grow at a CAGR of 10.3% during the Forecast Period [180-Pages] | Confirmed by Research Dive
April 20, 2022 09:00 ET | Research Dive
New York, USA, April 20, 2022 (GLOBE NEWSWIRE) -- Research Dive states that the global cancer stem cells market is estimated to garner a revenue of $1,722.7 million by 2026, and rise at a CAGR of...